Cargando…

Serious bronchospasm induced by cisatracurium besylate: A case report

RATIONALE: Cis-atracurium as an intermediate-acting non-depolarizing neuromuscular blocker is widely used clinically with less causing cyclic fluctuations and less histamine release. As the use rate increases, allergic reactions and anaphylactoid reactions caused by cis-atracurium increase. PATIENT...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ning, Zhang, Yaozhong, Hu, Yu, Yang, Qiyao, Su, Zhenbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051963/
https://www.ncbi.nlm.nih.gov/pubmed/33847670
http://dx.doi.org/10.1097/MD.0000000000025516
_version_ 1783679837692493824
author Wang, Ning
Zhang, Yaozhong
Hu, Yu
Yang, Qiyao
Su, Zhenbo
author_facet Wang, Ning
Zhang, Yaozhong
Hu, Yu
Yang, Qiyao
Su, Zhenbo
author_sort Wang, Ning
collection PubMed
description RATIONALE: Cis-atracurium as an intermediate-acting non-depolarizing neuromuscular blocker is widely used clinically with less causing cyclic fluctuations and less histamine release. As the use rate increases, allergic reactions and anaphylactoid reactions caused by cis-atracurium increase. PATIENT CONCERNS: A 23-year-old woman underwent laparoscopic bariatric surgery. Airway spasm occurred after anesthesia induction and the operation was suspended. After adjustment, the anesthesia was performed with the same anesthetic scheme again. After induction, skin flushing and airway resistance increased, then the symptoms were relieved. When the cis-atracurium was given again, the symptoms of airway spasm reappeared immediately, and after communicating with the family, the operation was successfully completed with rocuronium. DIAGNOSES: Serious bronchospasm induced by cisatracurium besylate. INTERVENTIONS: The patient was undergone assisted ventilation with continuous positive airway pressure (CPAP) and aminophylline 250 mg, methylprednisolone 80 mg were given intravenously. OUTCOMES: There was no any obvious discomfort in the patient's self-report during the next day's visit. The patient was discharged 7 days later. No abnormalities were observed during following 4 weeks. LESSONS: Although the anaphylactoid reactions caused by cis-atracurium are rare, the bronchospasm and anaphylactic shock caused by it greatly increase the risk of anesthesia, which should be taken seriously by clinicians. Increased vigilance in diagnosis, and treatment are essential to prevent aggravation and further complication.
format Online
Article
Text
id pubmed-8051963
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-80519632021-04-19 Serious bronchospasm induced by cisatracurium besylate: A case report Wang, Ning Zhang, Yaozhong Hu, Yu Yang, Qiyao Su, Zhenbo Medicine (Baltimore) 3300 RATIONALE: Cis-atracurium as an intermediate-acting non-depolarizing neuromuscular blocker is widely used clinically with less causing cyclic fluctuations and less histamine release. As the use rate increases, allergic reactions and anaphylactoid reactions caused by cis-atracurium increase. PATIENT CONCERNS: A 23-year-old woman underwent laparoscopic bariatric surgery. Airway spasm occurred after anesthesia induction and the operation was suspended. After adjustment, the anesthesia was performed with the same anesthetic scheme again. After induction, skin flushing and airway resistance increased, then the symptoms were relieved. When the cis-atracurium was given again, the symptoms of airway spasm reappeared immediately, and after communicating with the family, the operation was successfully completed with rocuronium. DIAGNOSES: Serious bronchospasm induced by cisatracurium besylate. INTERVENTIONS: The patient was undergone assisted ventilation with continuous positive airway pressure (CPAP) and aminophylline 250 mg, methylprednisolone 80 mg were given intravenously. OUTCOMES: There was no any obvious discomfort in the patient's self-report during the next day's visit. The patient was discharged 7 days later. No abnormalities were observed during following 4 weeks. LESSONS: Although the anaphylactoid reactions caused by cis-atracurium are rare, the bronchospasm and anaphylactic shock caused by it greatly increase the risk of anesthesia, which should be taken seriously by clinicians. Increased vigilance in diagnosis, and treatment are essential to prevent aggravation and further complication. Lippincott Williams & Wilkins 2021-04-16 /pmc/articles/PMC8051963/ /pubmed/33847670 http://dx.doi.org/10.1097/MD.0000000000025516 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle 3300
Wang, Ning
Zhang, Yaozhong
Hu, Yu
Yang, Qiyao
Su, Zhenbo
Serious bronchospasm induced by cisatracurium besylate: A case report
title Serious bronchospasm induced by cisatracurium besylate: A case report
title_full Serious bronchospasm induced by cisatracurium besylate: A case report
title_fullStr Serious bronchospasm induced by cisatracurium besylate: A case report
title_full_unstemmed Serious bronchospasm induced by cisatracurium besylate: A case report
title_short Serious bronchospasm induced by cisatracurium besylate: A case report
title_sort serious bronchospasm induced by cisatracurium besylate: a case report
topic 3300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051963/
https://www.ncbi.nlm.nih.gov/pubmed/33847670
http://dx.doi.org/10.1097/MD.0000000000025516
work_keys_str_mv AT wangning seriousbronchospasminducedbycisatracuriumbesylateacasereport
AT zhangyaozhong seriousbronchospasminducedbycisatracuriumbesylateacasereport
AT huyu seriousbronchospasminducedbycisatracuriumbesylateacasereport
AT yangqiyao seriousbronchospasminducedbycisatracuriumbesylateacasereport
AT suzhenbo seriousbronchospasminducedbycisatracuriumbesylateacasereport